EMAIL THIS PAGE TO A FRIEND

Annals of neurology

Fyn inhibition rescues established memory and synapse loss in Alzheimer mice.


PMID 25707991

Abstract

Currently no effective disease-modifying agents exist for the treatment of Alzheimer disease (AD). The Fyn tyrosine kinase is implicated in AD pathology triggered by amyloid-ß oligomers (Aßo) and propagated by Tau. Thus, Fyn inhibition may prevent or delay disease progression. Here, we sought to repurpose the Src family kinase inhibitor oncology compound, AZD0530, for AD. The pharmacokinetics and distribution of AZD0530 were evaluated in mice. Inhibition of Aßo signaling to Fyn, Pyk2, and Glu receptors by AZD0530 was tested by brain slice assays. After AZD0530 or vehicle treatment of wild-type and AD transgenic mice, memory was assessed by Morris water maze and novel object recognition. For these cohorts, amyloid precursor protein (APP) metabolism, synaptic markers (SV2 and PSD-95), and targets of Fyn (Pyk2 and Tau) were studied by immunohistochemistry and by immunoblotting. AZD0530 potently inhibits Fyn and prevents both Aßo-induced Fyn signaling and downstream phosphorylation of the AD risk gene product Pyk2, and of NR2B Glu receptors in brain slices. After 4 weeks of treatment, AZD0530 dosing of APP/PS1 transgenic mice fully rescues spatial memory deficits and synaptic depletion, without altering APP or Aß metabolism. AZD0530 treatment also reduces microglial activation in APP/PS1 mice, and rescues Tau phosphorylation and deposition abnormalities in APP/PS1/Tau transgenic mice. There is no evidence of AZD0530 chronic toxicity. Targeting Fyn can reverse memory deficits found in AD mouse models, and rescue synapse density loss characteristic of the disease. Thus, AZD0530 is a promising candidate to test as a potential therapy for AD.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB2501245
Anti-DLG4 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1405717
Anti-DLG4 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA010122
Anti-DLG4 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1401115
Anti-DLG4 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB2105773
Anti-DLG4 antibody produced in rabbit, affinity isolated antibody
M2442 Anti-phospho-N-Methyl D-Aspartate NR2B Subunit (pTyr1472) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
D2510
Deoxycholic acid, ≥98% (HPLC)
C24H40O4
D4297
Deoxycholic acid, BioXtra, ≥98% (HPLC)
C24H40O4
30960
Deoxycholic acid, ≥99.0% (T)
C24H40O4
457965
Europium, chip, in mineral oil
Eu
261092
Europium, ingot, under oil, 99.9% trace rare earth metals basis
Eu
GF17199827
Europium, foil, 25x25mm, thickness 0.1mm, as rolled, 99.95%
Eu
GF49978029
Europium, foil, 50x50mm, thickness 0.1mm, as rolled, 99.95%
Eu
GF36861701
Europium, wire reel, 50mm, diameter 1.0mm, hard, 99.95%
Eu
GF07712670
Europium, wire reel, 100mm, diameter 1.0mm, hard, 99.95%
Eu
GF64084158
Europium, wire reel, 200mm, diameter 1.0mm, hard, 99.95%
Eu
GF10519084
Europium, powder, 1g, max. particle size 250micron, 99.9%
Eu
M2643
Magnesium sulfate, BioReagent, suitable for cell culture, suitable for insect cell culture
MgSO4
203726
Magnesium sulfate, ≥99.99% trace metals basis
MgSO4
M3409
Magnesium sulfate solution, for molecular biology, 1.00 M±0.04 M
MgSO4
83266
Magnesium sulfate solution, BioUltra, for molecular biology
MgSO4
SAB5200002
Monoclonal Anti-DLG4 antibody produced in mouse, clone 6G6, 1 mg/mL, purified immunoglobulin
SAB5200003
Monoclonal Anti-DLG4 antibody produced in mouse, clone 7E3, 1 mg/mL, purified immunoglobulin
P246
Monoclonal Anti-PSD95 antibody produced in mouse, clone 7E3-1B8, purified immunoglobulin, buffered aqueous solution